Immediate Impact

77 standout
Sub-graph 1 of 21

Citing Papers

Current status and future trends of the global burden of MASLD
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
2 intermediate papers

Works of Haley Bush being referenced

Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis
2018
Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2017

Author Peers

Author Last Decade Papers Cites
Haley Bush 315 174 118 18 397
Kushala Abeysekera 247 139 93 27 351
Tamoore Arshad 337 176 122 15 402
Suzanne Williams 244 163 95 24 355
Mohammad Nasser Kabbany 320 165 142 20 367
Praveen Kumar Conjeevaram Selvakumar 311 163 136 28 380
Lea Ladegaard Grønkjær 236 155 34 31 393
Elena Younossi 350 182 134 14 403
Jillian Kallman Price 248 133 106 17 340
Josep Aubá 228 81 131 12 349
Jorge E. Angeles 390 119 243 11 453

All Works

Loading papers...

Rankless by CCL
2026